Data presented at Digestive Disease Week (DDW) 2025 demonstrated safety and treatment success in patients treated for recurrent C. Diff infection with REBYOTA administered by colonoscopy Data also ...
Why The Research Is Interesting: Clostridium difficile infection (CDI) causes inflammation of the colon and severe diarrhea. The infection occurs when normal gut bacteria are disrupted. Fecal ...
Experts focus on the current state of fecal microbiota transplant as a treatment option for clostridium difficile infection. Video Player is loading.
As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new ...
In developing a treatment for Clostridium difficile—an infection that can cause life-threatening diarrhea—Ferring Pharmaceuticals has had to dig deep in a decadelong pursuit, experimenting with ...
Fecal microbiota transplantation (FMT) delivered via oral capsule or colonic delivery demonstrated similar safety and effectiveness for recurrent Clostridioides difficile infection (CDI) in a ...
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback